New insights into the mechanism of action of amphetamines
AE Fleckenstein, TJ Volz, EL Riddle… - Annu. Rev …, 2007 - annualreviews.org
Amphetamine is a psychostimulant commonly used to treat several disorders, including
attention deficit, narcolepsy, and obesity. Plasmalemmal and vesicular monoamine transporters, …
attention deficit, narcolepsy, and obesity. Plasmalemmal and vesicular monoamine transporters, …
Bath salts and synthetic cathinones: an emerging designer drug phenomenon
CL German, AE Fleckenstein, GR Hanson - Life sciences, 2014 - Elsevier
Synthetic cathinones are an emerging class of designer drugs abused for psychostimulant
and hallucinogenic effects similar to cocaine, methylenedioxymethamphetamine (MDMA), or …
and hallucinogenic effects similar to cocaine, methylenedioxymethamphetamine (MDMA), or …
4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse
…, DG Wilkins, GR Hanson, AE Fleckenstein - … of Pharmacology and …, 2011 - ASPET
The designer stimulant 4-methylmethcathinone (mephedrone) is among the most popular of
the derivatives of the naturally occurring psychostimulant cathinone. Mephedrone has been …
the derivatives of the naturally occurring psychostimulant cathinone. Mephedrone has been …
Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity
AE Fleckenstein, JW Gibb, GR Hanson - European journal of pharmacology, 2000 - Elsevier
Many psychostimulants alter plasmalemmal monoaminergic transporter function. Some,
such as cocaine, prevent the reuptake of newly released dopamine, serotonin or …
such as cocaine, prevent the reuptake of newly released dopamine, serotonin or …
Regulation of the dopamine and vesicular monoamine transporters: pharmacological targets and implications for disease
…, LM McFadden, GR Hanson, AE Fleckenstein - Pharmacological …, 2015 - ASPET
Dopamine (DA) plays a well recognized role in a variety of physiologic functions such as
movement, cognition, mood, and reward. Consequently, many human disorders are due, in part…
movement, cognition, mood, and reward. Consequently, many human disorders are due, in part…
Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment
K Curtin, AE Fleckenstein, RJ Robison… - Drug and alcohol …, 2015 - Elsevier
Background Despite widespread use of methamphetamine and other amphetamine-type
stimulants (METH/AMPH), little is known about the long-term medical consequences of METH/…
stimulants (METH/AMPH), little is known about the long-term medical consequences of METH/…
Mechanisms of methamphetamine-induced dopaminergic neurotoxicity
EL Riddle, AE Fleckenstein, GR Hanson - The AAPS journal, 2006 - Springer
… Kokoshka JM , Vaughan RA , Hanson GR , Fleckenstein AE . Nature of methamphetamine-…
Baucum AJ, 2nd , Rau KS , Riddle EL , Hanson GR , Fleckenstein AE . Methamphetamine …
Baucum AJ, 2nd , Rau KS , Riddle EL , Hanson GR , Fleckenstein AE . Methamphetamine …
Methamphetamine rapidly decreases vesicular dopamine uptake
…, GR Hanson, AE Fleckenstein - Journal of …, 2000 - Wiley Online Library
Vesicular sequestration is important in the regulation of cytoplasmic concentrations of
monoamines such as dopamine. Moreover, recent evidence suggests that increases in …
monoamines such as dopamine. Moreover, recent evidence suggests that increases in …
Rapid and reversible effects of methamphetamine on dopamine transporters
AE Fleckenstein, RR Metzger, DG Wilkins… - … of Pharmacology and …, 1997 - ASPET
Reactive oxygen species decrease dopamine transporter (DAT) functionin vitro. Because of
this, and the finding that METH administration causes oxygen radical formation in vivo, the …
this, and the finding that METH administration causes oxygen radical formation in vivo, the …
Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants
JM Brown, GR Hanson, AE Fleckenstein - Journal of Pharmacology and …, 2001 - ASPET
The plasmalemmal dopamine (DA) transporter (DAT) is a principal site of action for cocaine.
This report presents the novel finding that in addition to inhibiting DAT function, cocaine …
This report presents the novel finding that in addition to inhibiting DAT function, cocaine …